LAEKNA-B(02105),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02105 LAEKNA-B

Trading 12-11 14:47:40

15.930

+0.220

+1.40%

High16.270	Low15.550	Vol1.36M
Open15.960	D1 Closing15.710	Amplitude4.58%
Mkt Cap7.10B	Tradable Cap7.10B	Total Shares446.00M
T/O21.70M	T/O Rate0.31%	Tradable Shares446.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"LAEKNA-B","latestPrice":15.93,"timestamp":1765435655735,"preClose":15.71,"halted":0,"volume":1363000,"delay":0,"floatShares":446000000,"shares":446000000,"eps":-0.7835721619884861,"marketStatus":"Trading","change":0.22,"latestTime":"12-11 14:47:40","open":15.96,"high":16.27,"low":15.55,"amount":21703410,"amplitude":0.045831,"askPrice":15.95,"askSize":500,"bidPrice":15.92,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-0.7206685078652559,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1765440600000},"marketStatusCode":2,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":15.71,"openAndCloseTimeList":[[1765416600000,1765425600000],[1765429200000,1765440000000]],"volumeRatio":0.613747,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02105","defaultTab":"news","newsList":[{"id":"1130982436","title":"HK Stock Movement | LAEKNA-B (02105) Rises Over 5% in Early Trading, LAE002 Expected to Submit NDA in First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1130982436","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130982436?lang=en_us&edition=fundamental","pubTime":"2025-12-04 10:08","pubTimestamp":1764814097,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) surged more than 5% in early trading, reaching HK$16.9 with a turnover of HK$28.7 million. The company recently signed an exclusive agreement with Qilu Pharmaceutical, granting Qilu...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1134728285","title":"10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=1134728285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134728285?lang=en_us&edition=fundamental","pubTime":"2025-12-03 19:38","pubTimestamp":1764761917,"startTime":"0","endTime":"0","summary":"On December 3, 2025, the \"10th Zhitong Capital Market Annual Conference & Listed Companies Awards Ceremony,\" jointly hosted by leading Hong Kong and U.S. stock information platform Zhitong Finance...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860","02431","00460","BK1504","02551","LU0072462343.USD","06963","LU1808992512.USD","HK0000306701.USD","BK1216","09639","01911","LU1917777945.USD","02525","LU1008478684.HKD","02420","BK1582","BK1502","LU0214875030.USD","LU2177674079.SGD","BK1516","IE00B0JY6N72.USD","02567","BK1114","01952","02121","02595","02696","BK1591","LU1794554557.SGD","02627","BK1222","BK1225","IE0003851619.USD","LU0082770016.USD","01600","BK1136","LNNGY","LU0326950275.SGD","LU0823414478.USD","LU0164865239.USD","LU0541501648.USD","LU0348784397.USD","BK1167","80992","01739","BK1128","01318","LU1969619763.USD","LU2125910500.SGD","LU0359201612.USD","00363","LU0149721374.USD","LU1366334578.USD","01519","02105","02511","LU2153591404.USD","SG9999015952.SGD","02509","03800","BK1608","02150","LU1048588211.SGD","BK1587","SGXZ90724238.SGD","BK1100","LU2097828805.USD","BK1158","LU1880383366.USD","IE00B8L5B284.USD","02650","LU0541502299.USD","HK0000252152.HKD","01877","02556","01405","LU1282649067.USD","BK1175","02167","LU0314109678.HKD","LU1497733631.SGD","LU1115378108.SGD","09956","LU2023250504.SGD","06657","BK1227","BK1583","LU0228659784.USD","09959","LU0819121731.USD","BK1139","LU0823426480.USD","LU1770036033.HKD","BK1523","LU0049112450.USD","LU0251144936.SGD","SG9999006514.SGD","02488","BK1526","BK1528","LU0084288322.USD","LU0164880469.USD","LU0431992006.USD","LU0456827905.SGD","LU2399975544.HKD","BK1179","01907","IE00BD6J9T35.USD","BK1557","BK1598","BK1131","06086","01070","00017","LU0871576103.HKD","LU1508157978.USD","BK1500","BK1616","02018","LU2328871848.SGD","LU0737861772.HKD","LU1868837565.USD","SG9999015986.USD","BK1609","LU0620787316.HKD","00798","00960","LU0708995583.HKD","BK1589","BK1539","BK1147","BK1592","06168","01880","06613","LU0211977185.USD","BK1594","06913","BYDDY","IE00B8HQ1Z84.USD","06862","BK1168","LU1961090484.USD","02276","BK1233","01458","02411","LU0329678170.USD","LU0348783233.USD","03939","LU1226287529.USD","LU1868837722.USD","BK1169","LU0261950470.USD","BK1148","02670","BK1593","BK1125","LU0455707207.USD","03738","BK1559","SG9999015978.USD","SG9999001226.SGD","BK1141","BK1127","BK1190","IE00B5MMRT66.SGD","SG9999011746.SGD","BK1606","BK1224","01117","HK0000252160.HKD","SG9999001051.SGD","LU0588546209.SGD","02587","06919","LU0345776255.USD","LU0417516571.SGD","BK1230","03650","LU0052756011.USD","LU0052750758.USD","IE00BQXX3C00.GBP","BK1184","LU1039395188.USD","BK1189","BK1258","LU1226287875.USD","LU0244354667.USD","LU0269904917.USD","LU1868838027.USD","LU2348774022.SGD","02453","LU2294711713.HKD","BK1117","LU2778985437.USD","IE00BYV24P56.USD","LU0261947096.USD","SG9999001069.SGD","BK1556","03677","02013","LU1023057109.AUD","BK1207","LU0516422440.USD","LU2506952253.HKD","LU1211504680.USD","LU0499858602.USD","09699","06683","09955","01969","BK1521","02100","LU0588545904.SGD","02197","BK1150","06618","LU0880133367.SGD","SG9999006597.SGD","BK1240","BK1552","LU2039709279.SGD","02331","02228","BK1198","01809","SGXZ86797644.SGD","02279","LU2153592121.USD","02273","02315","BK1219","LU0502904849.HKD","02469","LU0762540952.USD","SG9999003461.SGD","LU2663582299.SGD","LU0231483743.USD","86618","LU0593848301.USD","LU0417516902.SGD","02145","02858","BK1183","02298","LU2008162690.USD","LU0043850808.USD","02552","LU0823038988.USD","LU0140636845.USD","BK1109","BK1518","LU1366334651.USD","IE00BGV7N243.SGD","LU1328615791.USD","LU2298064838.USD","BK1519","BK1585","LU0289739343.SGD","LU0348766576.USD","LU0650527681.SGD","LU0456846285.SGD","BK1155","LU0143863198.USD","SG9999015945.SGD","BK1524","06821","LU1282649810.SGD","LU2449936058.SGD","01640","LU0310800965.SGD","SG9999002562.SGD","BK1542","LU0359202008.SGD","BK1154","LU0048575426.USD","LU1235295612.USD","LU2460026573.USD","IE00BMCWC346.EUR","03709","IE00BZ08YT58.USD","LU1224709979.USD","00512","03681","01276","LU0823039010.USD","LU0640798160.USD","00699","LU0039217434.USD","BK1578","01735","IE00BZ08YR35.GBP","002594","BK1550","SG9999000418.SGD","06090","09911","09660","01211","06996","IE00BZ08YS42.EUR","LU2476274720.SGD","LU1719994722.HKD","02565","01378","LU0072913022.USD","BK1235","09636","LU0823414551.USD","LU0254981946.USD","LU1152091168.USD","BK1600","BK1116","BK1605","BK1221","LU0229945570.USD","02256","LU0289961442.SGD","BK1228","BK1604","BK1512","BK1515","IE00BQXX3F31.USD","LU1720050803.USD","00777","02096","LU0348827113.USD","LU0819123356.HKD","BK1554","LU0588545730.USD","LU2238339852.HKD","BK1607","HYDD.SI","01651","LU1267930227.SGD","LU0164872284.USD","00020","82020","LU0259732245.USD","02460","02400","BK1610","01530","IE0008368742.USD","09877","LU1880383440.USD","02142","LU0173614495.USD","LNVGY","LU0348767384.USD","LU0791591158.USD","09690","LU0572940350.SGD","LU0979878070.USD","00999","LU0348825331.USD","BK1124","00855","02533","LU0315179316.USD","LU0289960550.SGD","LU0175139822.USD","02590","LU0594300179.USD","LU0143863784.USD","LU0702159699.USD","SGXZ62798434.SGD","LU0505663152.USD","LU0605514214.HKD","09890","82331","LU1634259391.SGD","BK1178","LU0417516738.SGD","IE00BPRC5H50.USD","LU0327786744.USD","BK1160","IE0031814852.USD","LU0516422366.SGD","BK1191","LU1166156734.SGD","LU1102505929.USD","BK1257","BK1170","09927","06058","LU0320764599.SGD","BK1144","BK1164","LU0737861699.HKD","LU2348773727.SGD","BK1575","BK1237","LU0594300419.USD","LU1522347837.USD","LU0611395673.USD","LU1813983027.USD","BK1209","SG9999002950.SGD","03998","LU1861219969.SGD","03145","BK1229","BK1617","LU0865486749.SGD","02157","02889","02419","HK0000306685.HKD","BK1142","09992","BK1137","LU0831093199.SGD","09678","00451","BK1548","LU2249611893.SGD","LU0384037296.USD","BK1555","02382","06609","81211","SG9999000459.SGD","BK1193","LU0348805143.USD","02629","BK1197","BK1119","02598","09880","LU0370786039.SGD","ANPDY","LU1242518857.USD","00003","01833","LU0531970944.HKD","BK1522","LU0488056044.USD","BK1549","LU1303224171.USD","LU1807302812.USD","LU0287142896.SGD","LU0499858438.USD","LU0823397103.USD","BK1619","02268","02171","LU0856984785.SGD","LU0251143458.SGD","HK0000320264.USD","BK1186","BK1577","01585","09926","LU2097828474.EUR","02190","BK1579","06138","LU1981816686.USD","SG9999014674.SGD","LU0107464264.USD","00884","00875","LU0048580855.USD","BK1212","LU2424517915.HKD","BK1161","IE00B29SXG58.USD","LU0082770016.SGD","00384","LU1481107354.HKD","LU0572944931.SGD","LU2106854487.HKD","BK1509","LU1226287792.SGD","SG9999002463.SGD","LU0823397285.USD","HK0000165453.HKD","BK1111","SG9999001903.USD","01681","BK1553","LU0868486357.SGD","BK1163","LU1328277881.USD","IE00BGHQDM52.EUR","BK1530","BK1590","LU2506951792.HKD","LU2357125470.USD","00826","03396","BK1571","06608","01164","02158","LU0572939691.SGD","06060","BK1095","LU0588545490.SGD","LU2360107325.USD","SG9999002828.SGD","BK1239","LU0274383008.USD","BK1200","LU1251922891.USD","06988","09985","02886","02392","BK1595","LU0449515922.USD","LU2097828631.EUR","LU0463099449.HKD","03658","BK1574","BK1588","LU0511384066.AUD","BK1566","LU0634319403.HKD","LU0165289439.USD","IE0032431581.USD","LU0261950983.USD","BK1195","LU0449509016.USD","02177","LU1046422090.SGD","LU1634259557.SGD","02616","IE00BVYPNP33.GBP","06677","LU0791590937.USD","BK1126","01520","06855","IE0009570106.USD","LU2045819591.USD","SG9999001093.SGD","LU0509642566.USD","BK1618","03836","HK0000320223.HKD","LU0561508036.HKD","BK1520","00867","03896","BK1215","00305","02380","BK1214","80020","IE0003795394.USD","LU0067412154.USD","BK1171","01119","01773","LU0315178854.USD","LU1226288253.USD","LU0048597586.USD","IE00B543WZ88.USD","LU0516423174.USD","BK1188","LU0540923850.HKD","BK1134","BK1104","IE0008369823.USD","LU0516422952.EUR","02498","BK1110","LU0348735423.USD","00992","09923","LU2488822045.USD","BK1613","LU1831875114.USD","06160","LU1675838814.USD","LU1497733557.USD","00302","02057","LU0164939612.USD","00135","LU1861214812.USD","BK1596","LU1242518931.SGD","09878","01471","02020","LU0828237510.HKD","IE00BQXX3D17.EUR","01783","BK1247","LU1497734951.SGD","LU2242644610.SGD","LU3063872942.SGD","02506","02436","IE00BVYPNQ40.USD","BK1527","LU1951186391.HKD","09990","LU0531971595.HKD","BK1194","01093","LU0469268626.HKD","LU1770034418.SGD","00666","BK1151","LU1226288170.HKD","LU0345775950.USD","LU0128525689.USD","BK1560","LU0543330566.HKD","06633","00136","00656","BK1564","02155","LU2543165471.USD","BK1220","01762","BK1132","LU1939255532.USD","LU0329678337.USD","LU0823426308.USD","BK1096","00267","IE00B0169L03.USD","BK1253","BK1544","LU2476274308.USD","BK1586","01333","LU0307460666.USD","LU1960683339.HKD","LU0501845795.SGD","SG9999000475.SGD","02451","LU0823437842.USD","HK0000500386.USD","LU0054450605.USD","02250","IE00B031HY20.USD","LU0054237671.USD","LU1993786604.SGD","BK1531","LU0516423091.SGD","09919","LU0011963245.USD","LU0051755006.USD","01818","IE0034224299.USD","SG9999004220.SGD","00300","BK1540","LU2097828714.EUR","LU2097828557.USD","LU1152091754.HKD","LU1188198961.HKD","SG9999004311.SGD","LU1102505762.USD","00382","06100","LU1956131251.USD","BK1615","BK1597","06069","01440","BK1541","LU1974910355.USD","LU0828238088.HKD","LU0359201885.HKD","06186","IE00B031J352.USD","BK1140","01177","09961","09996","03680","01384","01939","00861","LU0264606111.USD","01448","BK1143"],"gpt_icon":1},{"id":"1172872567","title":"Laekna, Inc. (02105) Reports Unchanged Share Structure in November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1172872567","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172872567?lang=en_us&edition=fundamental","pubTime":"2025-12-03 17:25","pubTimestamp":1764753950,"startTime":"0","endTime":"0","summary":"Laekna, Inc. (02105) published its monthly return detailing the share capital structure for the period ended 30 November 2025. The authorized share capital remained at 5,000,000,000 ordinary shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"gpt_icon":0},{"id":"1177117741","title":"HK Stock Movement | LAEKNA-B (02105) Surges Over 6%, Industry Expects LAE002's Peak Sales in China to Reach RMB 2 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1177117741","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177117741?lang=en_us&edition=fundamental","pubTime":"2025-12-01 11:30","pubTimestamp":1764559816,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) rose more than 6%, with a gain of 4.92% at the time of writing, trading at HK$17.27 and a turnover of HK$32.15 million. On November 12, LAEKNA announced the licensing of its breast...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HXC","DRAG","BK4588","ASHR","BK4585","FXI","BK4614","KWEB","CQQQ","02105","BK1161","CWEB","ASHS","MCHI","YINN","CHAU"],"gpt_icon":1},{"id":"1168384821","title":"HK Stock Movement | LAIKNA-B (02105) Surges Over 15%, Up 40% This Month Following BD Deal for LAE002","url":"https://stock-news.laohu8.com/highlight/detail?id=1168384821","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168384821?lang=en_us&edition=fundamental","pubTime":"2025-11-27 10:32","pubTimestamp":1764210751,"startTime":"0","endTime":"0","summary":"LAIKNA-B (02105) surged more than 15%, extending its monthly gain to over 40%. At the time of writing, the stock rose 15.38% to HK$16.95, with a turnover of HK$58.22 million. The rally follows the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2586724475","title":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats up","url":"https://stock-news.laohu8.com/highlight/detail?id=2586724475","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586724475?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:39","pubTimestamp":1764077944,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upRewrites paragraph 1, adds Lilly valuation milestone in paragraph 3, updates with Novo trial details in paragraphs 9-0. Promising results of Novo Nordisk's NOVOb.CO experimental obesity drug, amycretin, from a mid-stage trial could give the drugmaker much-needed heft to reclaim lost ground in the weight-loss market, which is projected to reach $150 billion by next decade.Novo said the drug appeared safe and well tolerated, with mostly mild-to-moderate gastrointestinal side effects. Late-stage trials are planned for 2026. Amycretin has a dual-mode action, targeting GLP-1 and amylin hormones.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4N3X10QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","VKTX","LU0225771236.USD","LU1069347547.HKD","SG9999015945.SGD","LU2168564065.EUR","SG9999015986.USD","IE00BLSP4239.USD","LU0823416689.USD","LU2746668461.USD","LU1023059063.AUD","MTSR","SRRK","AMGN","LU0557290698.USD","LU1551013342.USD","03165","IE0004445239.USD","SG9999011175.SGD","LU0079474960.USD","LU0265550359.USD","SG9999014542.SGD","LU0738911758.USD","LU1061106388.HKD","LU2265009873.SGD","AZN.UK","LU0353189680.USD","MRK","LU0109391861.USD","03933","GPCR","BK4592","ALT","LU0949170772.SGD","LU0553294199.USD","LU1057294990.SGD","LU0094547139.USD","OPK","02105","LU2168563687.JPY","03692","LU0820561909.HKD","LU2063271972.USD","LU1066051225.USD","LU2168564149.EUR","LU0964806797.USD","SG9999013999.USD","LU0198837287.USD"],"gpt_icon":1},{"id":"1117424956","title":"Riding the Hong Kong Stock Rally: Bull Market Dawns in the East 2026 – 10th Zhitong Finance Capital Markets Annual Conference Invites You to a Capital Feast","url":"https://stock-news.laohu8.com/highlight/detail?id=1117424956","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117424956?lang=en_us&edition=fundamental","pubTime":"2025-11-18 08:56","pubTimestamp":1763427395,"startTime":"0","endTime":"0","summary":"As the fourth technological revolution sweeps across the globe, with AI and large model technologies reaching critical breakthroughs, capital engines are driving the revaluation of Chinese assets at...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","LU0348767384.USD","BK1171","00699","LU2488822045.USD","BK1521","IE00BMCWC346.EUR","02453","BK1221","02096","BK1542","BK1110","SG9999001069.SGD","09878","BK1139","02670","BK1574","02886","IE00BPRC5H50.USD","BK1579","00363","LU2460026573.USD","02142","06100","BK1144","BK1587","BK1137","BK1606","LU1497733631.SGD","00305","BK1207","02561","BK1186","02627","BK1552","BK1140","00196","LU1497733557.USD","SG9999003461.SGD","BK1619","02157","03738","BK1175","BK1524","02105","BK1202","LU0417516902.SGD","BK1531","06919","06682","09959","02858","02411","BK1578","BK1593","LU1808992512.USD","LU2778985437.USD","BK1591","BK1224","02567","BK1228","LU1634259557.SGD","SG9999002950.SGD","BK1577","02509","00302","BK1506","00861","BK1583","IE00B5MMRT66.SGD","SG9999015978.USD","BK1191","BK1596","02551","01164","01651","02177","BK1148","BK1095","02420","BK1100","BK1586","00382","BK1183","BK1555","BK1125","09911","00826","BK1529","BK1147","01762","BK1124","02279","BK1132","BK1131","LU1522347837.USD","02533","02256","BK1161","BK1188","BK1163","BK1178","00552","06996","BK1194","00604","02488","02380","LU0348766576.USD","02268","LU1497734951.SGD","IE00B543WZ88.USD","09860","LU1634259391.SGD","BK1155","06609","BK1518","HK0000252152.HKD","02431","09678","00867","SG9999014674.SGD","BK1229","BK1609","01809","06090","01318","IE00BGHQDM52.EUR","LU0348825331.USD","02587","BK1582","SG9999004220.SGD","06660","BK1258","00855","BK1193","BK1116","BK1141","BK1114","BK1516","BK1592","02171","03658","BK1216","00003","SG9999015945.SGD","IE00BVYPNQ40.USD","02511","BK1142","06069","BK1618","09996","BK1608","03315","01333","01167","BK1104","BK1150","LU2476274720.SGD","BK1225","HK0000252160.HKD","BK1556","BK1594","LU2476274308.USD","09919","06608","BK1209","IE00BVYPNP33.GBP","02616","01773","SG9999015952.SGD","06633","BK1585","01969","BK1500","BK1109","BK1613","01681","BK1539","IE00BYV24P56.USD","01907","06677","HK0000500386.USD","01783","02167","01228","BK1230","BK1527","00290","03145","BK1530","BK1595","SG9999015986.USD","BK1219"],"gpt_icon":0},{"id":"1194686074","title":"LAEKNA-B (02105) Surges Over 9% Again as Breast Cancer Drug Candidate LAE002 Secures 2.045 Billion Yuan BD Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1194686074","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194686074?lang=en_us&edition=fundamental","pubTime":"2025-11-17 14:56","pubTimestamp":1763362581,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) rose over 9% again, with a 6.71% increase at the time of writing, trading at HK$14.32 and a turnover of HK$92.66 million. On November 12, LAEKNA licensed the China rights for its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1154421719","title":"HK Stock Movement | LAIKNA-B (02105) Rises Nearly 7% Against Market Trend, Secures RMB 2.045 Billion BD Deal for Star Breast Cancer Target, Strengthens Core Business in Muscle Gain and Fat Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1154421719","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154421719?lang=en_us&edition=fundamental","pubTime":"2025-11-14 10:30","pubTimestamp":1763087419,"startTime":"0","endTime":"0","summary":"LAIKNA-B (02105) surged nearly 7% against the broader market trend. At the time of writing, the stock was up 2.88%, trading at HK$19 with a turnover of HK$27.711 million. The company announced via...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"1104226063","title":"HK Movers | Biomedical Stocks Jump With CStone Pharmaceuticals up 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104226063","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104226063?lang=en_us&edition=fundamental","pubTime":"2025-11-14 10:24","pubTimestamp":1763087071,"startTime":"0","endTime":"0","summary":"Biomedical stocks jumped in Hong Kong. CStone Pharmaceuticals rose 13%; Ascletis Pharma rose 11%; Sirnaomics rose 9%; Laekna rose 7%; PegBio Co rose 6%; Immunotech Biopharm rose 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5d27790606b64b3231c65f4df87c0e89","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","01672","02257","02565","02616","02105"],"gpt_icon":0},{"id":"1198788693","title":"HK Movers | Biomedical Stocks Jump With BeOne Medicines and Biocytogen up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198788693","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198788693?lang=en_us&edition=fundamental","pubTime":"2025-11-13 09:52","pubTimestamp":1762998775,"startTime":"0","endTime":"0","summary":"Biomedical stocks jumped in Hong Kong. BeOne Medicines and Biocytogen Pharmaceuticals rose 7%; 3SBio rose 6%; Innovent Biologics and Duality Biotherapeutics rose 5%; Laekna rose 3%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"93ca2ea8f560905425dc4dda4a045e37","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","01530","06160","02315","02105","09606"],"gpt_icon":0},{"id":"2582534893","title":"BUZZ-HK-listed Laekna jumps most in 7 weeks on Qilu licence deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2582534893","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582534893?lang=en_us&edition=fundamental","pubTime":"2025-11-12 11:29","pubTimestamp":1762918156,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed Laekna jumps most in 7 weeks on Qilu licence deal   ** Shares of Laekna Inc 2105.HK jump 8.5% to HK$12.28, their biggest intraday pct gain since September 26 ** Stock hit its highest point since November 5, and on track for third consecutive session of gains, if current trend holds** The developer of innovative therapies for cancer, liver diseases and obesity said it has granted China's Qilu Pharmaceutical an exclusive licence for research, development, and commercialisation of breast and prostate cancer treatment LAE002  in China** Says the company is entitled to receive upfront and clinical development milestone payments up to 530 million yuan   upon new drug application approval in China** Says the company is eligible to receive up to 2.045 billion yuan  in total in upfront and milestone payments and is entitled to receive tiered royalties on future net sales of LAE002  at percentages ranging from the low teens to the low twenties** YTD, Laekna shares up 28.9%, Hang S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"gpt_icon":0},{"id":"1195708215","title":"LAEKNA-B (02105) Enters Exclusive Licensing Agreement with Qilu Pharma for LAE 002 (Afuresertib) in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1195708215","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195708215?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:28","pubTimestamp":1762907314,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) announced on November 12, 2025, that the group has entered into an exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (Qilu Pharma). Under the terms of the agreement,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1191","01477","02105"],"gpt_icon":0},{"id":"1121297168","title":"Laekna (2105.HK) Announces Exclusive License Agreement with Qilu Pharma for Afuresertib in the China Region","url":"https://stock-news.laohu8.com/highlight/detail?id=1121297168","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121297168?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:22","pubTimestamp":1762906956,"startTime":"0","endTime":"0","summary":"Laekna, Inc. (2105.HK) announced that on November 12, 2025, the company and Qilu Pharmaceutical Company Limited (Qilu Pharma) entered into an exclusive licensing agreement. Qilu Pharma gains rights...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"gpt_icon":0},{"id":"2582731625","title":"Laekna Grants Qilu Pharma Exclusive License for LAE002 in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2582731625","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582731625?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:12","pubTimestamp":1762906357,"startTime":"0","endTime":"0","summary":"Laekna Inc. announced that it has entered into an exclusive license agreement with Qilu Pharmaceutical Company Limited for the research, development, and commercialization of LAE002  in the China region, which includes Mainland China, Hong Kong SAR, Macau SAR, and Taiwan. The agreement grants Qilu Pharma exclusive rights in the specified territory. The company stated that this arrangement aims to accelerate regulatory approval and commercialization of LAE002, and that the upfront and milestone payments received will strengthen its financial position. Laekna Inc. also noted that discussions with other potential partners are ongoing to further advance the development and commercialization of its drug candidate assets.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL7c83nx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2582316472","title":"Laekna Inc - Entitled to Receive up to RMB530 Mln Upon Nda Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2582316472","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582316472?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:10","pubTimestamp":1762906254,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nFWN3WN1EW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"2582161723","title":"Laekna Inc - Qilu Pharma Granted Exclusive License for Lae002 in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2582161723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582161723?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:10","pubTimestamp":1762906254,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nFWN3WN1EW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02105","BK1161"],"gpt_icon":0},{"id":"1103987748","title":"Laekna, Inc. (02105) Releases Monthly Return for October 2025 with No Change in Issued Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1103987748","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103987748?lang=en_us&edition=fundamental","pubTime":"2025-11-06 17:23","pubTimestamp":1762421035,"startTime":"0","endTime":"0","summary":"Laekna, Inc. published its monthly return for the period ending 31 October 2025. The report shows no movement in the company’s issued share capital or treasury shares during the month. As of 31...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"gpt_icon":0},{"id":"1104739304","title":"LAE102 Opens Up New Horizons for Muscle Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1104739304","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104739304?lang=en_us&edition=fundamental","pubTime":"2025-10-16 08:54","pubTimestamp":1760576075,"startTime":"0","endTime":"0","summary":"The domestically developed weight loss and muscle growth compound LAE102 is making significant strides toward becoming a best-in-class (BIC) contender. On September 29, 來凱醫藥-B (02105) released Phase...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02105"],"gpt_icon":0},{"id":"2574737487","title":"Insider Sellers Might Regret Selling Laekna Shares at a Lower Price Than Current Market Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2574737487","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574737487?lang=en_us&edition=fundamental","pubTime":"2025-10-11 06:52","pubTimestamp":1760136775,"startTime":"0","endTime":"0","summary":"Laekna, Inc.'s (HKG:2105) stock price has dropped 10% in the previous week, but insiders who sold CN¥56m in stock over...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2105/laekna-shares/news/insider-sellers-might-regret-selling-laekna-shares-at-a-lowe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2105/laekna-shares/news/insider-sellers-might-regret-selling-laekna-shares-at-a-lowe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02105","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.laekna.com","stockEarnings":[{"period":"1week","weight":-0.0181},{"period":"1month","weight":0.4877},{"period":"3month","weight":0.0404},{"period":"6month","weight":-0.2907},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.6766}],"compareEarnings":[{"period":"1week","weight":-0.0085},{"period":"1month","weight":-0.0416},{"period":"3month","weight":-0.0209},{"period":"6month","weight":0.069},{"period":"1year","weight":0.2575},{"period":"ytd","weight":0.2732}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Laekna Inc is an investment holding company mainly engaged in the discovery, development and commercialization of innovative therapies for cancer, liver diseases and obesity. The Company is still in the research and development stage. The Company's pipeline products include Afuresertib (LAE002), LAE001, LAE109, LAE111, LAE112, LAE113, LAE117, LAE118, LAE119, LAE102, LAE103, LAE104, LAE105, LAE106, LAE120, LAE123, and others. The Afuresertib is an adenosine triphosphate (ATP) competitive AKT inhibitor. The LAE001 is an androgen synthesis inhibitor that can inhibit CYP17A1 and CYP11B2 at the same time. The Company mainly conducts business in the Chinese, America, European, Korean, and other markets.","exchange":"SEHK","name":"LAEKNA-B","nameEN":"LAEKNA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LAEKNA-B(02105),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LAEKNA-B(02105) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LAEKNA-B,02105,LAEKNA-B股票,LAEKNA-B股票老虎,LAEKNA-B股票老虎国际,LAEKNA-B行情,LAEKNA-B股票行情,LAEKNA-B股价,LAEKNA-B股市,LAEKNA-B股票价格,LAEKNA-B股票交易,LAEKNA-B股票购买,LAEKNA-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LAEKNA-B(02105),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LAEKNA-B(02105) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}